PaxMedica, Inc.
PXMD
$0.00
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -68.22% | -46.22% | -13.55% | -32.03% | 2.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -79.66% | -10.70% | -8.58% | -11.88% | 61.95% |
| Operating Income | 79.66% | 10.70% | 8.58% | 11.88% | -61.95% |
| Income Before Tax | 82.64% | 14.01% | 3.66% | -13.41% | 55.95% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 82.64% | 14.01% | 3.66% | -13.41% | 55.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 82.64% | 14.01% | 3.66% | -13.41% | 55.95% |
| EBIT | 79.66% | 10.70% | 8.58% | 11.88% | -61.95% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 98.14% | 90.33% | 90.35% | 80.45% | 75.53% |
| Normalized Basic EPS | 98.00% | 90.33% | 90.25% | 78.65% | 77.08% |
| EPS Diluted | 98.14% | 90.33% | 90.31% | 80.44% | 75.53% |
| Normalized Diluted EPS | 98.00% | 90.33% | 90.25% | 78.65% | 77.08% |
| Average Basic Shares Outstanding | 831.91% | 789.45% | 897.89% | 480.02% | 80.00% |
| Average Diluted Shares Outstanding | 831.91% | 789.45% | 897.89% | 480.02% | 80.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |